ArticleClinical ophthalmology (Auckland, N.Z.)2025
Efficacy and Safety of Intravitreal Brolucizumab in Chronic Central Serous Chorioretinopathy: A Retrospective Cohort Study [Response to Letter].
Somnath Chakraborty et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.